A meta‐analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease

Hernán, Miguel A., Takkouche, Bahi, Caamaño‐Isorna, Francisco, Gestal‐Otero, Juan J.·2002·Annals of Neurology
DOI 10.1002/ana.10277

Cited by (817)

Items 501–600 of 817

  1. Factors associated with phenoconversion of idiopathic rapid eye movement sleep behavior disorder: a prospective study
    Yuan Yuan, Yuan Li, Hui Zhang, Yajie Zang, Xiaonan Liu, Yue Hou, Shuqin Zhan, Yanning Cai, Wei Mao, Piu Chan · 2025 · npj Parkinson s Disease
  2. Association between serum myeloperoxidase enzyme activity and Parkinson’s disease status
    Emilio Fernández‐Espejo, María-del-Mar Guerra, Silvia Castellano · 2025 · npj Parkinson s Disease
  3. Effects of Hydroxyhydroquinone-reduced Coffee in Patients with Essential Hypertension
    Ryuji Ochiai, Tomonori Nagao, Yoshihisa Katsuragi, Ichiro Tokimitsu, Kazuo Funatsu, Haruo Nakamura · 2008 · Eisei kagaku
  4. Does treating schizophrenia reduce the chances of developing amyotrophic lateral sclerosis?
    Elijah W. Stommel, David J. Graber, Justin Montanye, Jeffrey A. Cohen, Brent T. Harris · 2007 · Medical Hypotheses
  5. On the Interaction Between Nicotine and Metal(II) Ions in Aqueous Solutions
    Carla Manfredi, Stefania Vero, Ermanno Vasca, D. Perrotta, Marco Trifuoggi, Ilaria Sorrentino, Diego Ferri · 2016 · Journal of Solution Chemistry
  6. Association between coffee drinking and telomere length in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
    Bella Steiner, Leah M. Ferrucci, Lisa J. Mirabello, Qing Lan B, Wei Hu, Linda M. Liao, Sharon A. Savage, Immaculata De Vivo, Richard B. Hayes, Preetha Rajaraman et al. · 2020 · PLoS ONE
  7. Patients with Parkinson’s disease predict a lower incidence of colorectal cancer
    Hongsheng Fang, Yunlan Du, Shuting Pan, Ming Zhong, Jia‐Yin Tang · 2021 · BMC Geriatrics
  8. Post Hoc Parkinson’s Disease: Identifying an Uncommon Disease in the Cardiovascular Health Study
    Thanh G.N. Ton, Samay Jain, Robert M. Boudreau, Evan L. Thacker, Elsa S. Strotmeyer, Anne B. Newman, W.T. Longstreth, Harvey Checkoway · 2010 · Neuroepidemiology
  9. Smoking in Patients with Parkinson's Disease: preliminary striatal DaT‐SPECT findings
    A. Gigante, G. Defazio, A. Asabella, M. Superbo, C. Ferrari, D. Liuzzi, G. Iliceto, P. Livrea, G. Rubini · 2016 · Acta Neurologica Scandinavica
  10. Neuroprotection and Dopamine Agonists
    Zvezdan Pirtošek, Dušan Flisar · 2004 · Advances in experimental medicine and biology
  11. Chemopreventive Properties of Coffee and Its Constituents
    Gernot Faustmann, Christophe Cavin, Armen K. Nersesyan, Siegfried Knasmüller · 2009
  12. Multiple catechols in human plasma after drinking caffeinated or decaffeinated coffee
    David S. Goldstein, Patti Sullivan, Abraham Corrales, Risa Isonaka, Janna Gelsomino, Jamie Cherup, Genessis Castillo, Courtney S. Holmes · 2021 · Journal of Chromatography B
  13. A predictive algorithm to identify ever smoking in medical claims-based epidemiologic studies
    Irene M. Faust, Mark N. Warden, Alejandra Camacho‐Soto, Brad Alan Racette, Susan Searles Nielsen · 2023 · Annals of Epidemiology
  14. Psychiatric and cognitive symptoms of Parkinson's disease: A life's tale
    Deborah Amstutz, Mário Sousa, Marie Elise Maradan‐Gachet, Ines Debove, Eugénie Lhommée, Paul Krack · 2024 · Revue Neurologique
  15. Coffee consumption and health
    Marino Petracco, Rinantonio Viani · 2005 · Elsevier eBooks
  16. Gene-environment interaction and Mendelian randomisation.
    Pierre L. Kolber, R. Krüger · 2019 · Revue neurologique (Paris)
  17. Nutritional aspects in Parkinson’s disease
    Paulina Gątarek, Joanna Kałużna‐Czaplińska · 2021 · Critical Reviews in Food Science and Nutrition
  18. Research Progress in the Pharmacological Effects and Synthesis of Nicotine
    Xiaoping Ye, Yanxin Zhang, Xiaoping Song, Qingchao Liu · 2022 · ChemistrySelect
  19. Risk of Parkinson’s disease in hepatitis B and C populations: a systematic review and meta-analysis
    Clyve Yu Leon Yaow, Ashley Shuen Ying Hong, Nicolette Zy-Yin Chong, Ryan Ian Houe Chong, Aaron Shengting Mai, Eng‐King Tan · 2023 · Journal of Neural Transmission
  20. Glutamate Receptor Gene GRIN2A, Coffee, and Parkinson Disease
    Taye H. Hamza, Erin M. Hill‐Burns, William K. Scott, Jeffery M. Vance, Stewart Alan Factor, Cyrus P. Zabetian, Haydeh Payami · 2014 · PLoS Genetics
  21. Caffeine Consumption and General Health in Secondary School Children: A Cross-sectional and Longitudinal Analysis
    Gareth Richards, Andrew Paul Smith · 2016 · Frontiers in Nutrition
  22. Chronic Nicotine Exposure Attenuates Methamphetamine-Induced Dopaminergic Deficits
    Paula L. Vieira‐Brock, Lisa M. McFadden, Shannon M. Nielsen, Jonathan D. Ellis, Elliot T. Walters, Kristen A. Stout, J. Michael McIntosh, Diana G. Wilkins, Glen R. Hanson, Annette E. Fleckenstein · 2015 · Journal of Pharmacology and Experimental Therapeutics
  23. Coffee, Genetic Variants, and Parkinson's Disease: Gene–Environment Interactions
    Naomi Yamada-Fowler, Peter Söderkvist · 2015 · Journal of Caffeine Research
  24. Association of coffee consumption with health-related quality of life and metabolic syndrome in Korean adults: based on 2013 ~ 2016 Korea National Health and Nutrition Examination Survey
    Hyesook Kim, You Jin Kim, Yeni Lim, Oran Kwon · 2018 · Journal of Nutrition and Health
  25. Non-genetic factors associated with the risk of Parkinson�s disease in Iranian patients
    N Hosseini tabatabaei · 2013 · Functional Neurology
  26. SMOKING DURATION, INTENSITY, AND RISK OF PARKINSON DISEASE
    Steven Robert Brenner · 2010 · Neurology
  27. Nicotine Has a Therapeutic Window of Effectiveness in a Drosophila melanogaster Model of Parkinson’s Disease
    Brady S. Mannett, Braden Capt, Krista Pearman, Lori M. Buhlman, John M. VandenBrooks, Gerald B. Call · 2022 · Parkinson s Disease
  28. Adenosinergic Pathway in Parkinson’s Disease: Recent Advances and Therapeutic Perspective
    Yuan Zhao, Xin Liu, Guofeng Yang · 2023 · Molecular Neurobiology
  29. Caffeine plus haloperidol reduces fatigue in an experimental model of Parkinson's disease – a prospective to A2AR-D2R heterodimer antagonism
    Ana Cristina de Bem Alves, Aderbal S. Aguiar · 2023 · Purinergic Signalling
  30. Association of CHRNA4 gene rs1044396 and rs1044397 polymorphisms with Parkinson’s disease symptoms and smoking
    Leyao Zhang, X.P. Zhang, Y.Q. Chen, Wei-Xin Ye · 2015 · Genetics and Molecular Research
  31. Premature or pathological aging: longevity
    Valdemiro Carlos Sgarbieri, Maria Teresa Bertoldo Pacheco · 2017 · Brazilian journal of food technology/Brazilian Journal of Food Technology
  32. Combating Dopaminergic Neurodegeneration in Parkinson’s Disease through Nanovesicle Technology
    Rubina Roy, Rajib Kumar Paul, Pallab Bhattacharya, Anupom Borah · 2023 · ACS Chemical Neuroscience
  33. Epidemiology and Clinical Diagnosis of Parkinson Disease
    Michael Kleinman, Samuel Frank · 2013 · PET Clinics
  34. The association between P arkinson's disease and anti‐epilepsy drug carbamazepine: a case–control study using the UK G eneral P ractice R esearch D atabase
    Áine Skow, Ian Douglas, Liam L Smeeth · 2013 · British Journal of Clinical Pharmacology
  35. Neuroactive β-Carbolines Norharman and Harman in Coffee
    Susana I.P. Casal · 2014 · Coffee in Health and Disease Prevention
  36. Investigation of non-motor symptoms in first-degree relatives of patients with Parkinson's disease
    Jiang-bing Liu, Junling Leng, Xinjiang Zhang, Zhao-xia Wang, Zuowei Duan, Chengjie Mao, Chun‐Feng Liu · 2018 · Parkinsonism & Related Disorders
  37. Coffee consumption is not associated with risk of multiple sclerosis: A Mendelian randomization study
    Hui Lü, Peng-Fei Wu, Wan Zhang, Kun Xia · 2020 · Multiple Sclerosis and Related Disorders
  38. Prospective comorbidity-matched study of Parkinson's disease and risk of mortality among women
    Anke C. Winter, Pamela M. Rist, Julie E. Buring, Tobias Kurth · 2016 · BMJ Open
  39. Commentary: Synaptic vesicle glycoprotein 2C (SV2C) modulates dopamine release and is disrupted in Parkinson disease
    Sachchida Nand, Hareram Birla, Walia Zahra, Saumitra Sen Singh, Surya Pratap Singh · 2018 · Frontiers in Synaptic Neuroscience
  40. Beta2-Adrenergic Suppression of Neuroinflammation in Treatment of Parkinsonism, with Relevance for Neurodegenerative and Neoplastic Disorders
    Mario A. Inchiosa · 2024 · Biomedicines
  41. Declining trends in the incidence of Parkinson's disease: A cohort study in Germany
    Anne Fink, Maria Angeliki S. Pavlou, Kirsten Roomp, Jochen G. Schneider · 2024 · Journal of Parkinson s Disease
  42. Predicting Phenoconversion in Isolated RBD: Machine Learning and Explainable AI Approach
    Yong-Woo Shin, Jung-Ick Byun, Jun‐Sang Sunwoo, Chae‐Seo Rhee, Jung Hwan Shin, Han‐Joon Kim, Ki‐Young Jung · 2025 · Clocks & Sleep
  43. Harnessing artificial intelligence for enhanced Parkinson’s disease management: Pathways, treatment, and prospects
    Mohsina F. Patwekar, Faheem Patwekar, Syed Sanaullah, Daniyal Shaikh, Ustad Almas, Rohit Sharma · 2023 · Trends in Immunotherapy
  44. Do physical exercise and reading reduce the risk of Parkinson’s disease? a cross-sectional study on factors associated with Parkinson’s disease in elderly Chinese veterans
    Yongming Zou, JP Tan, Nan Li, JS Yang, Bao-cheng Yu, JM Yu, Yiming Zhao, Luning Wang · 2015 · Neuropsychiatric Disease and Treatment
  45. Rapid Eye Movement Sleep Parasomnias
    Michael H. Silber, Erik K. St. Louis, Bradley F. Boeve · 2016 · Elsevier eBooks
  46. Clinical and Genetic Analysis of Costa Rican Patients With Parkinson's Disease
    Gabriel Torrealba Acosta, Eric Yu, Tanya Lobo-Prada, Javier Ruiz‐Martínez, Ana Gorostidi Pagola, Ziv Gan‐Or, Kenneth Carazo-Céspedes, Jean-François Trempe, Ignacio Fernandez Mata, Jaime Fornaguera Trías · 2021 · Frontiers in Neurology
  47. Visualizing disease associations: graphic analysis of frequency distributions as a function of age using moving average plots (MAP) with application to Alzheimer's and Parkinson's disease
    Haydeh Payami, Denise M. Kay, Cyrus P. Zabetian, Gerard D. Schellenberg, Stewart Alan Factor, Colin C. McCulloch · 2009 · Genetic Epidemiology
  48. Estrogen-related and other disease diagnoses preceding Parkinson’s disease
    Jeanne C. Latourelle · 2010 · Clinical Epidemiology
  49. Single-nucleotide polymorphisms (SNPs) and haplotype analysis in vascular endothelial growth factor (VEGF) gene in the patients with Parkinson disease and lung cancer
    Joong‐Seok Kim, Sung‐Vin Yim, In Song Koh, Jin Soo Choi, Ji-Yeon Yoo, Kwang-Soo Lee, Young Lim, Kweon-Haeng Lee · 2008 · Archives of Gerontology and Geriatrics
  50. Clinical evidence linking coffee and tea intake with Parkinson’s disease
    Kumar Manharlal Prakash, Eng‐King Tan · 2011 · Basal Ganglia
  51. Cost‐effectiveness of increasing the reach of smoking cessation interventions in Germany: results from the EQUIPTMOD
    Manuel B. Huber, Maximilian Präger, Kathryn Coyle, Doug Coyle, Adam Lester‐George, Marta Trapero‐Bertran, Bertalan Németh, Kei Long Cheung, Renee G. Stark, Matthias Vogl et al. · 2017 · Addiction
  52. Parkin deficiency prevents chronic ethanol-induced hepatic lipid accumulation through β-catenin accumulation
    Dong Hun Lee, Mi Hee Park, Chul Ju Hwang, Youngsoo Kim, Dae Yeon Hwang, Sang‐Bae Han, Jin Tae Hong · 2019 · Cell Communication and Signaling
  53. Parkinson disease and other synucleinopathies
    Thomas Gasser, Thomas Wichmann · 2022 · Elsevier eBooks
  54. β2-Adrenoceptor Agonists in Asthma or Chronic Obstructive Pulmonary Disease and Risk of Parkinson’s Disease: Nested Case-Control Study
    Anne Paakinaho, Miia Tiihonen, Heikki Olavi Koskela, Marjaana Koponen, Jari Tiihonen, Sirpa A. Hartikainen, Anna‐Maija Tolppanen · 2023 · Clinical Epidemiology
  55. Parkinson’s disease and occupational exposure to organic solvents in Finland: a nationwide case-control study
    Markku Sallmén, Igor Burstyn, Sanni Uuksulainen, Aki Koskinen, Christer Hublin, Markku Alarik Sainio · 2023 · Scandinavian Journal of Work Environment & Health
  56. Systematic replication of smoking disease associations using survey responses and EHR data in the All of Us Research Program
    David J. Schlueter, Lina Mahmoud Sulieman, Huan Mo, Jacob M. Keaton, Tracey M. Ferrara, Ariel Williams, Jun Qian, Onajia Stubblefield, Chenjie Zeng, Tam C. Tran et al. · 2023 · Journal of the American Medical Informatics Association
  57. Transforming neurodegenerative disorder care with machine learning: Strategies and applications
    Aya A. Galal, Ahmed A. Moustafa, Mohamed Salama · 2025 · Neuroscience
  58. Maladie de Parkinson : une maladie à forte composante environnementale ?
    Alexis Elbaz, Frédéric Moisan · 2010 · Revue Neurologique
  59. Diet, Alcohol, Obesity, Hyperuricemia, and Risk of Gout
    Hyon K. Choi · 2012 · Elsevier eBooks
  60. Test–retest repeatability of assessing environmental and lifestyle factors in Parkinson's disease
    C. Yip, Eng‐King Tan · 2008 · Movement Disorders
  61. The Role of Coffee in the Therapy of Parkinson ’s Disease
    Andrew Tran, Cecilia Yijun Zhang · 2015 · Journal of Alzheimer’s Disease & Parkinsonism
  62. Etiology and pathogenesis of Parkinson disease
    Joseph J. Jankovic, Mark Hallett, Michael S. Okun, Cynthia Comella, Stanley Fahn, Jennifer G. Goldman · 2021 · Elsevier eBooks
  63. Mitophagy could fight Parkinson’s disease through antioxidant action
    Anthea Di Rita, Flavie Strappazzon · 2019 · Reviews in the Neurosciences
  64. No definitive evidence for a role for the environment in the etiology of Parkinson's Disease
    John Hardy · 2006 · Movement Disorders
  65. Locally adapting digital health technologies to address the global challenge of Parkinson’s disease
    Karlo J. Lizárraga, Isabel Camargo Salazar, Christine E. Zizzi, Stefano E. Romero, José Centeno Arispe, Alejandro Vela Quico, Timothy Dye, Earl Ray Dorsey, Benjamín Castañeda · 2025 · Equity Neuroscience
  66. The temporal order of genetic, environmental, and pathological risk factors in Parkinson's disease: paving the way to prevention
    Cornelis Blauwendraat, Huw R. Morris, Kendall R. Van Keuren‐Jensen, Alastair John Noyce, Andrew Singleton · 2025 · The Lancet Neurology
  67. Influence of current and previous smoking on current phenotype in Parkinson's disease
    Shuichiro Neshige, Tomohiko Ohshita, Ryuji Neshige, Hirofumi Maruyama · 2021 · Journal of the Neurological Sciences
  68. The impact of lifetime coffee and tea loads on Multiple Sclerosis severity
    Andrei Ivashynka, Maurizio Angelo Leone, Nadia Barizzone, Aliona Cucovici, Roberto M. Cantello, Domizia Vecchio, Miriam Zuccalà, Alessandro Pizzino, Massimiliano Copetti, Sandra D’Alfonso et al. · 2021 · Clinical Nutrition ESPEN
  69. The protective role of cigarette smoking against Parkinson’s disease via moderation of the interaction between iron deposition in the nigrostriatal pathway and clinical symptoms
    Quanquan Gu, Xiaocao Liu, Qingze Zeng, Xiaojun Guan, Cheng Zhou, Tao Guo, Baorong Zhang, Minming Zhang · 2022 · Quantitative Imaging in Medicine and Surgery
  70. Coffee and disease: an overview with main emphasis on blood lipids and homocysteine
    Dag Steinar Thelle, Elisabeth Strandhagen · 2005 · Food & Nutrition Research
  71. Coffee and disease: an overview with main emphasis on blood lipids and homocysteine
    Dag Steinar Thelle, Elisabeth Strandhagen · 2005 · Scandinavian Journal of Nutrition
  72. Screening and Targeting Risk Factors for Prodromal Synucleinopathy: Taking Steps toward a Prescriptive Multi-modal Framework
    Lee E. Neilson, Joseph F. Quinn, Miranda M. Lim · 2023 · Aging and Disease
  73. Rauchen und Alkoholkonsum als Risikofaktoren einer Demenz im Alter
    Horst Bickel · 2006 · SUCHT - Zeitschrift für Wissenschaft und Praxis / Journal of Addiction Research and Practice
  74. CAFFEINE AND CHLOROGENIC ACIDS IN COFFEE AND EFFECTS ON SELECTED NEURODEGENERATIVE DISEASES
    Roseane Maria Maia Santos, Tracy Hunter, Nick Wright, Darcy Roberto Andrade Lima · 2013 · Journal of Pharmaceutical and Scientific Innovation
  75. Is Endotoxin an Environmental Cause of Parkinson’s Disease?
    J. H. Lange, Ines Niehaus, Kenneth William Thomulka · 2003 · Neuroepidemiology
  76. Coffee drinking, cigarette smoking, and Parkinson's disease
    William H. James · 2003 · Annals of Neurology
  77. Proposed mechanisms of neuroprotection for nicotine in Parkinson's disease
    Namrata Kumari, LD Cooke, Abby L. Olsen · 2025 · Journal of Parkinson s Disease
  78. Enfermedad de parkinson: criterios diagnósticos, factores de riesgo y de progresión, y escalas de valoración del estadio clínico
    Aracelly Castro Toro, Omar Buriticá · 2014 · DOAJ (DOAJ: Directory of Open Access Journals)
  79. Neuroinflammation as a Potential Mechanism Underlying Parkinsons Disease
    Carolina Cebrián, David L. Sulzer · 2017 · Elsevier eBooks
  80. Does glitazone treatment have a role on the prevention of Parkinson’s disease in adult diabetic population? A systematic review
    Jesús D. Meléndez‐Flores, Juan Manuel Millán-Alanís, Adrian González-Martínez, Neri Alejandro Álvarez‐Villalobos, Ingrid E. Estrada-Bellmann · 2020 · Metabolic Brain Disease
  81. The Promise of Mendelian Randomization in Parkinson’s Disease: Has the Smoke Cleared Yet for Smoking and Parkinson’s Disease Risk?
    Beate R. Ritz, Cynthia Kusters · 2022 · Journal of Parkinson s Disease
  82. Serum metabolomic characterization of PLA2G6-associated dystonia–parkinsonism: A case-control biomarker study
    Chen Chen, Min-Min Lou, Yi‐Min Sun, Fang Luo, Fengtao Liu, Su-Shan Luo, Wenyuan Wang, Jian Wang · 2022 · Frontiers in Neuroscience
  83. Caffeine and Parkinson’s Disease
    Astrid Nehlig · 2004 · CRC Press eBooks
  84. The a ssociation between personality and risk taking
    Gabriella M. Anic · 2007
  85. Perspectiva histórica y aspectos epidemiológicos de la enfermedad de Parkinson
    Silvia Inés García, Sergio Sauri Suárez, Erika Graciela Meza Dávalos, Juan Lucino Castillo · 2008 · Medicina Interna de México
  86. Current concepts on the etiology and pathogenesis of Parkinson disease
    Stanley Fahn, Joseph J. Jankovic, Mark Hallett · 2011 · Elsevier eBooks
  87. Time to wake up and smell the coffee? Coffee consumption and multiple sclerosis
    José M. A. Wijnands, Elaine Kingwell · 2016 · Journal of Neurology Neurosurgery & Psychiatry
  88. The Association Between Risk Taking And Personality
    Gabriella M. Anic · 2007 · Digital Commons - University of South Florida (University of South Florida)
  89. Caffeine, nicotine, cannabis, and psilocybin: Pharmacology, toxicology, and potential therapeutic uses of four naturally occurring psychoactive substances
    Samuel E Christen, Elias Bekka, Yasmin Schmid, Neal L. Benowitz, Evangelia Liakoni · 2025 · Swiss Medical Weekly
  90. Correcting for Endogeneity in Models with Bunching
    Carolina Caetano, Gregorio Caetano, Eric Reed Nielsen · 2023 · Journal of Business and Economic Statistics
  91. Molecular dynamics simulations reveal initial structural and dynamic features for the A2AR as a result of ligand binding
    Marlet Martínez‐Archundia, José Correa‐Basurto · 2013 · Molecular Simulation
  92. Caffeine Psychopharmacology and Effects on Cognitive Performance and Mood
    Jack E. James · 2012
  93. Parkinson Disease and Occupational and Environmental Exposure to Pesticides in a Region of Intense Agribusiness Activity in Brazil: A Case-Control Study.
    Grasiela Cristina Silva Botelho Silvestre, M. Ferreira, Sue Ellen Ferreira Modesto Rey de Figueiredo, Cristhiane Almeida Leite da Silva, H. Siqueira, Ageo Mário Cândido da Silva · 2020 · Journal of Occupational and Environmental Medicine
  94. Caffeine
    Jack E. James · 2010 · Springer eBooks
  95. Multiple Sclerosis
    Patrick Alfryn Lewis, Jennifer E. Spillane · 2018 · Elsevier eBooks
  96. Premorbid Personality and the Risk of Parkinson’s Disease
    Kelly L. Sullivan, James A. Mortimer, Wei Wang, Theresa A. Zesiewicz, H. James Brownlee, Amy R. Borenstein · 2014 · Journal of Neurology Research
  97. Epidemiology of Parkinson's disease
    Tereza Bartoníková, Kateřina Menšíková, Vladimí­r Janout, Petr Kaňovský · 2020 · Neurologie pro praxi
  98. The epidemiology of animal bite, scratch, and other potential rabies exposures, Louisiana.
    Gary A. Balsamo, Raoult C Ratard, Amanda L. Claudet · 2009 · PubMed
  99. Parkinson Disease and Other Synucleinopathies
    Thomas Gasser, Thomas Wichmann, Mahlon R. DeLong · 2014 · Elsevier eBooks
  100. Coffee and Parkinson's Disease
    Jing Wei Lim, Eng‐King Tan · 2012